BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 18573939)

  • 1. Cytokine expression in the colonic mucosa of human immunodeficiency virus-infected individuals before and during 9 months of antiretroviral therapy.
    Schulbin H; Bode H; Stocker H; Schmidt W; Zippel T; Loddenkemper C; Engelmann E; Epple HJ; Arastéh K; Zeitz M; Ullrich R;
    Antimicrob Agents Chemother; 2008 Sep; 52(9):3377-84. PubMed ID: 18573939
    [TBL] [Abstract][Full Text] [Related]  

  • 2. T(H)1 to T(H)2 shift of cytokines in peripheral blood of HIV-infected patients is detectable by reverse transcriptase polymerase chain reaction but not by enzyme-linked immunosorbent assay under nonstimulated conditions.
    Altfeld M; Addo MM; Kreuzer KA; Rockstroh JK; Dumoulin FL; Schliefer K; Leifeld L; Sauerbruch T; Spengler U
    J Acquir Immune Defic Syndr; 2000 Apr; 23(4):287-94. PubMed ID: 10836750
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Decreases in plasma TNF-alpha level and IFN-gamma mRNA level in peripheral blood mononuclear cells (PBMC) and an increase in IL-2 mRNA level in PBMC are associated with effective highly active antiretroviral therapy in HIV-infected patients.
    Brazille P; Dereuddre-Bosquet N; Leport C; Clayette P; Boyer O; Vildé JL; Dormont D; Benveniste O
    Clin Exp Immunol; 2003 Feb; 131(2):304-11. PubMed ID: 12562393
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [CYTOKINES DURING THE HUMAN IMMUNODEFICIENCY VIRUS INFECTION TYPE 1(HIV-1)].
    Selimova LM; Kalnina LB; Serebrovskaya LV; Ivanova LA; Gulyaeva AN; Nosik DN
    Vopr Virusol; 2016; 61(1):39-41. PubMed ID: 27145600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of type 1 and type 2 cytokines in HIV type 1-infected individuals: impact of highly active antiretroviral therapy.
    Imami N; Antonopoulos C; Hardy GA; Gazzard B; Gotch FM
    AIDS Res Hum Retroviruses; 1999 Nov; 15(17):1499-508. PubMed ID: 10580400
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of a year of highly active antiretroviral therapy on immune reconstruction and cytokines in HIV/AIDS patients.
    Yao Y; Luo Y; He Y; Zheng Y; Zhang Q; Zhou H; Zeng S; Chen Z; He B; He M
    AIDS Res Hum Retroviruses; 2013 Apr; 29(4):691-7. PubMed ID: 23151174
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intrahepatic mRNA expression in hepatitis C virus and HIV/hepatitis C virus co-infection: infiltrating cells, cytokines, and influence of HAART.
    Kuntzen T; Tural C; Li B; Feldmann G; Kupfer B; Nischalke HD; Clotet B; Sauerbruch T; Rockstroh JK; Spengler U
    AIDS; 2008 Jan; 22(2):203-10. PubMed ID: 18097222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Residual viraemia in HIV-1-infected patients with plasma viral load Ostrowski SR; Katzenstein TL; Pedersen BK; Gerstoft J; Ullum H
    Scand J Immunol; 2008 Dec; 68(6):652-60. PubMed ID: 19055701
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Altered clonogenic capability and stromal cell function characterize bone marrow of HIV-infected subjects with low CD4+ T cell counts despite viral suppression during HAART.
    Isgrò A; Leti W; De Santis W; Marziali M; Esposito A; Fimiani C; Luzi G; Pinti M; Cossarizza A; Aiuti F; Mezzaroma I
    Clin Infect Dis; 2008 Jun; 46(12):1902-10. PubMed ID: 18462177
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early initiation of highly active antiretroviral therapy fails to reverse immunovirological abnormalities in gut-associated lymphoid tissue induced by acute HIV infection.
    Tincati C; Biasin M; Bandera A; Violin M; Marchetti G; Piacentini L; Vago GL; Balotta C; Moroni M; Franzetti F; Clerici M; Gori A
    Antivir Ther; 2009; 14(3):321-30. PubMed ID: 19474466
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Viral suppression and immune restoration in the gastrointestinal mucosa of human immunodeficiency virus type 1-infected patients initiating therapy during primary or chronic infection.
    Guadalupe M; Sankaran S; George MD; Reay E; Verhoeven D; Shacklett BL; Flamm J; Wegelin J; Prindiville T; Dandekar S
    J Virol; 2006 Aug; 80(16):8236-47. PubMed ID: 16873279
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Over-expression of interleukin 10 in mucosal T cells of patients with active ulcerative colitis.
    Melgar S; Yeung MM; Bas A; Forsberg G; Suhr O; Oberg A; Hammarstrom S; Danielsson A; Hammarstrom ML
    Clin Exp Immunol; 2003 Oct; 134(1):127-37. PubMed ID: 12974765
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Magnitude of IFN-gamma production in HIV-1-infected children is associated with virus suppression.
    Reuben JM; Lee BN; Paul M; Kline MW; Cron SG; Abramson S; Lewis D; Kozinetz CA; Shearer WT
    J Allergy Clin Immunol; 2002 Aug; 110(2):255-61. PubMed ID: 12170266
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Incomplete normalization of regulatory t-cell frequency in the gut mucosa of Colombian HIV-infected patients receiving long-term antiretroviral treatment.
    Rueda CM; Velilla PA; Chougnet CA; Rugeles MT
    PLoS One; 2013; 8(8):e71062. PubMed ID: 23967152
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variation in the expression of human immunodeficiency virus RNA and cytokine mRNA in rectal mucosa during the progression of infection.
    Reka S; Garro ML; Kotler DP
    Lymphokine Cytokine Res; 1994 Dec; 13(6):391-8. PubMed ID: 7703312
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV DNA and immune alteration during successful HAART.
    Mamadou D; Yu-Huang Z; Xia C; Bo H; Hua-Ying Z; Yan H; Zi C; Qing L; Li-Wen Z; Mei H; Yun-Hai Y; Demba S; Aldebert D; Souleymane M
    Curr HIV Res; 2013 Jun; 11(4):255-62. PubMed ID: 23822818
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased HIV-1 mucosal replication is associated with generalized mucosal cytokine activation.
    McGowan I; Elliott J; Fuerst M; Taing P; Boscardin J; Poles M; Anton P
    J Acquir Immune Defic Syndr; 2004 Oct; 37(2):1228-36. PubMed ID: 15385729
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Partial restoration of cytokine profile despite reconstitution of cytomegalovirus-specific cell-mediated immunity in human immunodeficiency virus-infected patients during highly active antiretroviral treatment.
    Alfonzo M; Blanc D; Troadec C; Eliaszewicz M; Gónzalez G; Scott-Algara D
    Scand J Immunol; 2003 Apr; 57(4):375-83. PubMed ID: 12662301
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Interleukin-10-secreting CD4 cells from aged patients with AIDS decrease in-vitro HIV replication and tumour necrosis factor alpha production.
    Andrade RM; Lima PG; Filho RG; Hygino J; Milczanowski SF; Andrade AF; Lauria C; Brindeiro R; Tanuri A; Bento CA
    AIDS; 2007 Aug; 21(13):1763-70. PubMed ID: 17690575
    [TBL] [Abstract][Full Text] [Related]  

  • 20. IMMUNOLOGICAL PROFILES IN HIV POSITIVE PATIENTS FOLLOWING HAART INITIATION IN KIGALI, RWANDA.
    Twizerimana AP; Mwatha J; Musabyimana JP; Kayigi E; Harelimana Jde D; Karanja SM; Mutesa L
    East Afr Med J; 2014 Aug; 91(8):261-6. PubMed ID: 26862650
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.